Chronic Obstructive Pulmonary Disease
📧 Sign up to get email alerts when something new happens for Chronic Obstructive Pulmonary Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-11-10Clinical Trial Update: Co-administration of Olodaterol Respimat® and Tiotropium Handihaler® [Phase 3]
A Phase 3 study evaluating the safety and efficacy of co-administering Striverdi Respimat (olodaterol) and Spiriva (tiotropium) HandiHaler i…
-
CLINICAL_TRIALS trial_result · 2014-11-05Clinical Trial Update: Do the SPPB and 4-metre Gait Speed Predict Hospital Readmission in Patients Hospitalised for Acute Exacerbation if COPD?
This completed clinical trial evaluated whether the short physical performance battery (SPPB) and 4-meter gait speed can predict hospital re…
-
CLINICAL_TRIALS research · 2014-11-05Clinical Trial Update: Inhaler Technique Training [NA]
A clinical trial update about inhaler technique training for patients with asthma and chronic obstructive pulmonary disease, sponsored by No…
-
CLINICAL_TRIALS trial_result · 2014-10-31Clinical Trial Update: Single Ascending Dose Study of TRN-157 in Healthy Subjects [Phase 1]
A Phase 1 single ascending dose study of TRN-157 in healthy subjects has completed; the study evaluated safety, tolerability, and pharmacoki…
-
FDA approval · 2014-10-30FDA Approved: TUDORZA PRESSAIR — Supplemental Application (Covis Pharma US, Inc)
The FDA approved a supplemental application for Tudorza Pressair (aclidinium bromide) submitted by Covis Pharma US, Inc.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-10-30Clinical Trial Update: The Respiratory Physiology Variation of COPD Patients in Inspiratory Muscle Training [Phase 2, Phase 3]
This clinical trial update notes the completion of Phase 2 and Phase 3 studies evaluating inspiratory muscle training in patients with chron…
-
CLINICAL_TRIALS trial_result · 2014-10-29Clinical Trial Update: Effect of Indacaterol Maleate in Chronic Obstructive Pulmonary Disease (COPD) on Lung Volume and Related Dyspnea [Phase 4]
A Phase 4 clinical trial assessing the effect of indacaterol maleate on lung volume and dyspnea in chronic obstructive pulmonary disease pat…
-
CLINICAL_TRIALS trial_result · 2014-10-29Clinical Trial Update: Effect of Prolonged Decubitus on Nitric Oxide Concentration in Chronic Obstructive Pulmonary Disease [Phase 4]
A Phase 4 clinical trial evaluating the effect of prolonged decubitus on nitric oxide levels in chronic obstructive pulmonary disease has co…
-
CLINICAL_TRIALS trial_result · 2014-10-29Clinical Trial Update: Closing Volume Interpretation and Bronchodilators Effect [Phase 4]
Phase 4 clinical trial update evaluating closing volume interpretation and the effects of bronchodilators.
-
CLINICAL_TRIALS trial_result · 2014-10-29Clinical Trial Update: Acute Effect of Aclidinium on Hyperinflation and Ventilation Inhomogeneity in Severe COPD Patients [Phase 4]
This Phase 4 study evaluated the acute effects of aclidinium on hyperinflation and ventilation inhomogeneity in patients with severe chronic…
-
CLINICAL_TRIALS trial_result · 2014-10-28Clinical Trial Update: Randomized, Crossover Safety and Pharmacokinetics Study of PT010 [Phase 1]
A Phase 1 randomized, crossover study assessed the safety and pharmacokinetics of PT010 in COPD and has completed.
-
CLINICAL_TRIALS trial_result · 2014-10-27Clinical Trial Update: Study To Evaluate The Efficacy And Safety Of PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium Bromide [Phase 2]
Phase 2 study evaluating the efficacy and safety of PH-797804 in adults with moderate to severe COPD on a background of tiotropium. The tria…
-
FDA approval · 2014-10-23FDA Approved: TUDORZA PRESSAIR — Supplemental Application (Covis Pharma US, Inc)
The FDA approved a supplemental application for Tudorza Pressair (aclidinium bromide) submitted by Covis Pharma US, Inc.
-
CLINICAL_TRIALS trial_result · 2014-10-23Clinical Trial Update: AZD2423 Safety and Tolerability Study in Patients With Moderate and Severe Chronic Obstructive Pulmonary Disease(COPD) [Phase 2]
Phase 2 safety and tolerability trial update for AZD2423 in patients with moderate to severe chronic obstructive pulmonary disease; the stud…
-
CLINICAL_TRIALS trial_result · 2014-10-23Clinical Trial Update: Investigation of the Effect of Oral Treatment With 100 mg AZD2423 in Subjects With Mild Chronic Obstructive Pulmonary Disease (COPD) [Phase 2]
AstraZeneca-sponsored Phase 2 trial evaluating oral AZD2423 (100 mg) in adults with mild chronic obstructive pulmonary disease; results were…
-
FDA approval · 2014-10-21FDA Approved: TERBUTALINE SULFATE — Supplemental Application (Fresenius Kabi USA, LLC)
FDA approved a supplemental application for terbutaline sulfate from Fresenius Kabi USA, LLC, indicating an additional authorization related…
-
CLINICAL_TRIALS research · 2014-10-21Clinical Trial Update: Effect of Traditional Chinese Medicine on Outcomes in Patients With Severe / Very Severe COPD [Phase 3]
Phase 3 clinical trial evaluating the effect of Traditional Chinese Medicine on outcomes in patients with severe to very severe Chronic Obst…
-
CLINICAL_TRIALS trial_result · 2014-10-21Clinical Trial Update: An Efficacy Study of BCS Clearing the Oral Colonized Bacterium in Hospitalized Patients With COPD [Phase 4]
This document describes a Phase 4 efficacy trial of BCS Clearing the Oral Colonized Bacterium in hospitalized patients with Chronic Obstruct…
-
FDA label_change · 2014-10-17FDA Approved: COMBIVENT RESPIMAT — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Combivent Respimat to update the product labeling. Combivent Respimat is a combination inhal…
-
CLINICAL_TRIALS trial_result · 2014-10-17Clinical Trial Update: Ventilator Monitoring in Early Exacerbation Detection [NA]
A completed clinical trial sponsored by ResMed evaluated ventilator monitoring for early detection of exacerbations in patients with respira…
-
CLINICAL_TRIALS research · 2014-10-17Clinical Trial Update: Use of an Air Warming Mask for Exercise in Patients With COPD V1.0 [NA]
This clinical trial update assesses whether using an air warming mask during exercise improves outcomes in patients with chronic obstructive…
-
CLINICAL_TRIALS trial_result · 2014-10-16Clinical Trial Update: Mechanisms of Vascular Damage in Patients With Chronic Obstructive Pulmonary Disease [NA]
A completed clinical trial investigating mechanisms of vascular damage in patients with chronic obstructive pulmonary disease.
-
CLINICAL_TRIALS trial_result · 2014-10-13Clinical Trial Update: Exercise and Neutrophil Function in COPD [NA]
A completed clinical trial evaluated the effect of exercise on neutrophil function in chronic obstructive pulmonary disease.
-
CLINICAL_TRIALS trial_result · 2014-10-09Clinical Trial Update: Study of the Comparability of Ipratropium Bromide Hydrofluoroalkane (HFA)-134a Inhalation Aerosol to the Market Standard, Atrovent® Chlorofluorocarbon (CFC) Inhalation Aerosol, in Patients With Chronic Obstructive Pulmonary Disease [Phase 2]
A Phase 2 trial evaluated the comparability of ipratropium bromide HFA-134a inhalation aerosol to the Atrovent CFC inhalation aerosol in pat…
-
CLINICAL_TRIALS trial_result · 2014-10-07Clinical Trial Update: Efficacy of Helium/Oxygen Compared to Air/Oxygen in Severe Exacerbation of Chronic Obstructive Pulmonary Disease (COPD) [Phase 3]
A Phase 3 trial comparing helium/oxygen (Heliox) to air/oxygen in severe COPD exacerbations has been terminated.